Form4insider filings, from the source

SEC Form 4 · accession 0001144204-17-018882

Protea Biosciences Group, Inc. · PRGB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Ed Roberson
Director
Period of report
Mar 24, 2017
Accepted (ET)
Apr 4, 2017 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001335103

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F3Mar 24, 2017J400,000$0.00A1,005,456D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Class A Warrant (right to buy)F1,F2,F4$0.09Mar 24, 2017J400,000AMar 24, 2017Sep 24, 2018Common Stock400,0001,123,927D
Class B Warrant (right to buy)F1,F2,F4$0.1125Mar 24, 2017J400,000AMar 24, 2017Mar 24, 2022Common Stock400,0001,123,927D

Explanation of responses